Enlitic, Inc. (ASX:ENL)

Market Cap	9.16M -73.8%
Revenue (ttm)	4.40M +489.8%
Net Income	-23.27M
EPS	-0.05
Shares Out	833.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,356
Average Volume	3,117,798
Open	0.0100
Previous Close	0.0110
Day's Range	0.0100 - 0.0100
52-Week Range	0.0100 - 0.1100
Beta	-1.57
RSI	35.04
Earnings Date	Feb 27, 2026

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, and ultrasound images, as well as licenses its products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a platform that uses artificial intelligence to standardize medical imaging data; ENCOG, an AI enabled data anony...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ENL

Financial Performance

In 2024, Enlitic's revenue was $1.20 million, an increase of 115.54% compared to the previous year's $557,677. Losses were -$15.24 million, -2.02% less than in 2023.

Financial numbers in USD